Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-03-12 Bridger Gary Director Grant or award · Common Exchangeable Shares +36,502 $11.00 $402K 40,147
2014-03-12 Bridger Gary Director Conversion · Common Exchangeable Shares −40,147 0
2014-03-12 Bridger Gary Director Conversion · Series A-1 Exchangeable Shares −284,090 0
2014-03-12 Bridger Gary Director Conversion · Series A-1 Preferred Stock +284,090 0
2014-03-12 Bridger Gary Director Conversion · Series A-1 Preferred Stock −284,090 0
2014-03-12 Bridger Gary Director Conversion · Series A-2 Exchangeable Shares −189,393 0
2014-03-12 Bridger Gary Director Conversion · Series A-2 Preferred Stock +189,393 0
2014-03-12 Bridger Gary Director Conversion · Series A-2 Preferred Stock −189,393 0
2014-03-12 Bridger Gary Director Conversion · Series B-1 Exchangeable Shares −326,538 0
2014-03-12 Bridger Gary Director Conversion · Series B-1 Preferred Stock +326,538 0
2014-03-12 Bridger Gary Director Conversion · Series B-1 Preferred Stock −326,538 0
2014-03-12 Bridger Gary Director Conversion · Series B-2 Exchangeable Shares −325,035 0
2014-03-12 Bridger Gary Director Conversion · Series B-2 Preferred Stock +325,035 0
2014-03-12 Bridger Gary Director Conversion · Series B-2 Preferred Stock −325,035 0
2014-03-12 Bridger Gary Director Conversion · Series C Exchangeable Shares −378,786 0
2014-03-12 Bridger Gary Director Conversion · Series C Preferred Stock +378,786 0
2014-03-12 Bridger Gary Director Conversion · Series C Preferred Stock −378,786 0
2014-03-12 PFIZER INC 10% owner Conversion +962,603 962,603
2014-03-12 PFIZER INC 10% owner Purchase +272,727 $11.00 $3.0M 1,235,330
2014-03-12 PFIZER INC 10% owner Conversion · Series B-1 Preferred Stock −334,420 0

Page 26 of 27 · 537 trades